Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Five new Gaucher disease mutations

E Beutler1, T Gelbart, A Demina

  • 1Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037, USA.

Blood Cells, Molecules & Diseases
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effectiveness of lucid dreaming therapy in patients with nightmares: A systematic review.

L'Encephale·2023
Same author

Prodromal substantia nigra sonography undermines suggested association between substrate accumulation and the risk for GBA-related Parkinson's disease.

European journal of neurology·2019
Same author

Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease.

Blood cells, molecules & diseases·2017
Same author

Treatment patterns from 647 patients with Gaucher disease: An analysis from the Gaucher Outcome Survey.

Blood cells, molecules & diseases·2016
Same author

Anthropometric adjustments are helpful in the interpretation of BMD and BMC Z-scores of pediatric patients with Prader-Willi syndrome.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2016
Same author

Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease.

Blood cells, molecules & diseases·2012
Same journal

Compound heterozygous variants in F7 gene causing severe factor VII deficiency without bleeding: A genotypic and laboratory analysis.

Blood cells, molecules & diseases·2026
Same journal

Propofol attenuates H<sub>2</sub>O<sub>2</sub>-induced senescence in human umbilical vein endothelial cells by activating the NRF2/HO-1 axis.

Blood cells, molecules & diseases·2026
Same journal

Is it time to implement a hemorheology passport in sickle cell disease?

Blood cells, molecules & diseases·2026
Same journal

From blood viscosity to a hemorheology passport: Making sickle-cell monitoring clinically actionable.

Blood cells, molecules & diseases·2026
Same journal

A real-world analysis of polycythemia vera at two comprehensive cancer centers in Cali, Colombia.

Blood cells, molecules & diseases·2026
Same journal

Sickle Cell Disease: Can genetic variability influence pregnancy outcomes?

Blood cells, molecules & diseases·2026
See all related articles

Researchers identified five new mutations in patient DNA, including two "lethal" mutations causing Type I disease. The study also documented a rare 1448G mutation, distinct from the common 1448C variant.

Area of Science:

  • * Molecular genetics and human disease research.
  • * Focus on genetic mutations and their clinical impact.

Background:

  • * Genetic analysis of individuals with unidentified alleles is crucial for understanding disease mechanisms.
  • * Previous studies have identified various mutations, but novel variants require continuous discovery.

Observation:

  • * Single-stranded conformation polymorphism (SSCP) analysis and sequencing were employed on DNA from 17 individuals.
  • * Twenty unidentified alleles were investigated, leading to the identification of new genetic variations.

Findings:

  • * Five novel mutations were discovered: 245T, 259T, 635G, 914C del, and IVS10(+2).
  • * Two identified mutations (914C del and IVS10(+2)) are classified as null or

Implications:

Related Experiment Videos

  • * The identification of these new mutations refines our understanding of genetic disease, particularly Type I disease.
  • * Distinguishing between rare and common mutations, like 1448G and 1448C, is vital for accurate diagnosis and patient management.
  • * This research contributes to the growing database of genetic variations and their associated phenotypes.